Polycystic kidney disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Polycystic kidney disease}} | {{Polycystic kidney disease}} | ||
{{ | {{CMG}} {{AE}} | ||
==Overview== | ==Overview== | ||
Revision as of 13:15, 25 November 2013
|
Polycystic kidney disease Microchapters |
|
Differentiating Polycystic kidney disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic kidney disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Polycystic kidney disease medical therapy |
|
Risk calculators and risk factors for Polycystic kidney disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Treatment
Treatment of ADPKD is targeted at managing symptoms and disease complications. There have been no treatments associated with disease regression or slowing of cysts formation.[1]
Hypertension
Hematuria
Urinary Tract Infections
Pain
Kidney Stones
Renal Failure
References
- ↑ Grantham JJ (2008). "Clinical practice. Autosomal dominant polycystic kidney disease". N Engl J Med. 359 (14): 1477–85. doi:10.1056/NEJMcp0804458. PMID 18832246.